Table 1.
Attenuation strategy | Vaccine strain | Serovar; strain; relevant genotype |
Relevant phenotype | Ref |
---|---|---|---|---|
Chemical mutagenesis |
Ty21a | Typhi; Ty2; ΔrpoS ΔgalE ΔgalK ΔilvD ΔvexD |
Natural RpoS-dependent sensitivity to environmental stressors; defective synthesis of LPS; auxotrophic for isoleucine and valine; defective synthesis of Vi |
(69) |
Engineered deletions in rpoS |
χ9639* | Typhi; Ty2; ΔrpoS |
Natural RpoS-dependent sensitivity to environmental stressors |
(90) |
χ9640* | Typhi; Ty2; rpoS+ |
Engineered RpoS-mediated resistance to environmental stressors |
(90) | |
χ9633* | Typhi; ISP1820; rpoS+ |
Natural RpoS-mediated resistance to environmental stressors |
(90) | |
Engineered deletions in phoP/phoQ |
Ty800 | Typhi; Ty2; ΔrpoS ΔphoP ΔphoQ |
Natural RpoS-dependent sensitivity to environmental stressors; defective in pH and osmolarity induction of invasion virulence factors |
(94) |
Ty1033ǂ | Typhi; Ty2; ΔrpoS ΔphoP ΔphoQ |
Natural RpoS-dependent sensitivity to environmental stressors; defective in pH and osmolarity induction of invasion virulence factors |
(96) | |
LH1160ǂ |
Typhimurium; ATCC 14028; ΔphoP ΔphoQ |
Defective in pH and osmolarity induction of invasion virulence factors |
(95) | |
Engineered deletions in ssaV |
M01ZH09 | Typhi; Ty2; ΔrpoS ΔaroC ΔssaV |
Natural RpoS-dependent sensitivity to environmental stressors; auxotrophic for aromatic amino acids; defective for proper secretion of SPI-2 effector proteins |
(97) (99, 100) (101) (102) |
WT05 |
Typhimurium; TML; ΔaroC ΔssaV |
Auxotrophic for aromatic amino acids; defective for proper secretion of SPI-2 effector proteins |
(97) | |
Engineered deletions in aroC, aroD, and htrA |
CVD 908 | Typhi; Ty2; ΔrpoS ΔaroC ΔaroD |
Natural RpoS-dependent sensitivity to environmental stressors; auxotrophic for aromatic amino acids |
(105) |
CVD 908- htrA |
Typhi; Ty2; ΔrpoS ΔaroC ΔaroD ΔhtrA |
Natural RpoS-dependent sensitivity to environmental stressors; auxotrophic for aromatic amino acids; sensitive to environmental heat shock |
(107) | |
CVD 909 | Typhi; Ty2; ΔrpoS Ptac-tviA ΔaroC ΔaroD ΔhtrA |
Natural RpoS-dependent sensitivity to environmental stressors; constitutive expression of TviA regulator and Vi antigen; auxotrophic for aromatic amino acids; sensitive to environmental heat shock |
(77) (108) (110) |
These vaccines were engineered as live vector vaccines, carrying additional chromosomal mutations, as well as also carrying multicopy plasmids expressing a pneumococcal foreign antigen. However, all candidate vaccines carried the same attenuating lesions and differed only with respect to parental strain used (Ty2 vs ISP1820) and the presence of rpoS.
These vaccines were engineered as live vector vaccines, carrying one additional chromosomal deletion in the purB gene, as well as also carrying multicopy plasmids encoding both purB and the foreign antigen urease from Helicobacter pylori. However, both S. Typhi and S. Typhimurium candidate vaccines were isogenic for the attenuating lesions tested in clinical trials.